• by floundy on 5/30/2025, 6:02:26 PM

    Good. Why should MRNA get 10% of their market cap in free government research handouts when there's other pharmaceutical companies that have been far more successful at making vaccines. MRNA literally has two products.

    This is a dying one trick pony, the ultimate COVID meme stock, that has lost 95% of its peak market capitalization. One of the top 15 or so pharma companies will probably buy them out when the market cap gets to $3-5B.